Medication Nonadherence in Diabetes
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the longitudinal effects of medication nonadherence (MNA) on key costs and estimate potential savings from increased adherence using a novel methodology that accounts for shared correlation among cost categories. RESEARCH DESIGN AND METHODS: Veterans with type 2 diabetes (740,195) were followed from January 2002 until death, loss to follow-up, or December 2006. A novel multivariate, generalized, linear, mixed modeling approach was used to assess the differential effect of MNA, defined as medication possession ratio (MPR) ≥0.8 on healthcare costs. A sensitivity analysis was performed to assess potential cost savings at different MNA levels using the Consumer Price Index to adjust estimates to 2012 dollar value. RESULTS: Mean MPR for the full sample over 5 years was 0.78, with a mean of 0.93 for the adherent group and 0.58 for the MNA group. In fully adjusted models, all annual cost categories increased ∼3% per year (P = 0.001) during the 5-year study time period. MNA was associated with a 37% lower pharmacy cost, 7% lower outpatient cost, and 41% higher inpatient cost. Based on sensitivity analyses, improving adherence in the MNA group would result in annual estimated cost savings ranging from ∼$661 million (MPR <0.6 vs. ≥0.6) to ∼$1.16 billion (MPR <1 vs. 1). Maximal incremental annual savings would occur by raising MPR from <0.8 to ≥0.8 ($204,530,778) among MNA subjects. CONCLUSIONS: Aggressive strategies and policies are needed to achieve optimal medication adherence in diabetes. Such approaches may further the so-called “triple aim” of achieving better health, better quality care, and lower cost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
The Triple Aim: Care, Health, And Cost
Berwick, D. M., Nolan, T. W., & Whittington, J. (2008) · Health Affairs · doi:10.1377/hlthaff.27.3.759 · Cited by 5,136
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Interventions to Enhance Patient Adherence to Medication Prescriptions: Scientific Review
McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002) · JAMA · doi:10.1001/jama.288.22.2868 · Cited by 1,176 · cited 2×
“In general, these investigators concluded that most successful methods for improving chronic medication adherence were complex, labor intensive, and not predictably effective (19).”
BackgroundReview of statistical methods for analysing healthcare resources and costs
Mihaylova, B., Briggs, A., O'Hagan, A., & Thompson, S. G. (2011) · Health Economics · doi:10.1002/hec.1653 · Cited by 767 · cited 2×
“In addition, most analyses fail to appropriately account for the shared correlation among cost variables (11).”
BackgroundDoes Free Care Improve Adults' Health?: Results from a Randomized Controlled Trial
Brook, R. H., Ware, J. E., Rogers, W. H., Keeler, E. B., Davies, A. R., Donald, C. A., Goldberg, G. A., Lohr, K. N., Masthay, P. C., & Newhouse, J. P. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312083092305 · Cited by 666 · cited 1×
“This is consistent with an earlier experience in the Rand health insurance experiment (25); although we should note that our study was not designed to specifically examine the effects of copayments on medication adherence.”
ResultHanlon, J. T., Weinberger, M., Samsa, G. P., Schmader, K. E., Uttech, K. M., Lewis, I. K., Cowper, P. A., Landsman, P. B., Cohen, H. J., & Feussner, J. R. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89519-8 · Cited by 612
Impact of Recent Increase in Incidence on Future Diabetes Burden
Narayan, K. M. V., Boyle, J. P., Geiss, L. S., Saaddine, J. B., & Thompson, T. J. (2006) · Diabetes Care · doi:10.2337/dc06-1136 · Cited by 602 · cited 2×
“$100 billion spent each year on avoidable hospitalizations (1,2).”
BackgroundMiller, D. R., Safford, M. M., & Pogach, L. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.suppl_2.b10 · Cited by 425 · cited 1×
“hypoglycemic agents in 2002 based on a previously validated algorithm (12).”
Method
Cited by
Economic impact of medication non-adherence by disease groups: a systematic review
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016982 · Cited by 900
Polonsky, W., & Henry, R. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s106821 · Cited by 784
Adherence and health care costs
McGuire, M., & Iuga (2014) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s19801 · Cited by 708
Importance of family/social support and impact on adherence to diabetic therapy
Miller, T., & DiMatteo, R. (2013) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s36368 · Cited by 437
Medication Adherence With Diabetes Medication: A Systematic Review of the Literature
Capoccia, K., Odegard, P. S., & Letassy, N. (2016) · The Diabetes Educator · doi:10.1177/0145721715619038 · Cited by 291
Insulin Access and Affordability Working Group: Conclusions and Recommendations
Cefalu, W. T., Dawes, D. E., Gavlak, G., Goldman, D., Herman, W. H., Van Nuys, K., Powers, A. C., Taylor, S. I., Yatvin, A. L., & on behalf of the Insulin Access and Affordability Working Group (2018) · Diabetes Care · doi:10.2337/dci18-0019 · Cited by 256
Rajagopalan, H., Cherrington, A. D., Thompson, C. C., Kaplan, L. M., Rubino, F., Mingrone, G., Becerra, P., Rodriguez, P., Vignolo, P., Caplan, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0383 · Cited by 216
Berkowitz, S. A., Meigs, J. B., DeWalt, D., Seligman, H. K., Barnard, L. S., Bright, O.-J. M., Schow, M., Atlas, S. J., & Wexler, D. J. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6888 · Cited by 212
McGovern, A., Tippu, Z., Hinton, W., Munro, N., Whyte, M., & de Lusignan, S. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13160 · Cited by 166
The ARMS-D out performs the SDSCA, but both are reliable, valid, and predict glycemic control
Mayberry, L. S., Gonzalez, J. S., Wallston, K. A., Kripalani, S., & Osborn, C. Y. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.09.010 · Cited by 129
Ravaut, M., Sadeghi, H., Leung, K. K., Volkovs, M., Kornas, K., Harish, V., Watson, T., Lewis, G. F., Weisman, A., Poutanen, T., et al. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00394-8 · Cited by 121
Nelson, L. A., Wallston, K. A., Kripalani, S. B., LeStourgeon, L. M., Williamson, S., & Mayberry, L. S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.046 · Cited by 138
Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review
Kennedy-Martin, T., Boye, K., & Peng, X. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s136639 · Cited by 110
Farmer, A. J., McSharry, J., Rowbotham, S., McGowan, L., Ricci‐Cabello, I., & French, D. P. (2016) · Diabetic Medicine · doi:10.1111/dme.12987 · Cited by 106
Out-of-Pocket Costs and Oral Cancer Medication Discontinuation in the Elderly
Kaisaeng, N., Harpe, S. E., & Carroll, N. V. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.7.669 · Cited by 108
Clifford, S., Perez-Nieves, M., Skalicky, A. M., Reaney, M., & Coyne, K. S. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.884491 · Cited by 99
Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents
Serbis, A., Giapros, V. I., Kotanidou, E. P., Galli‐Τsinopoulou, A., & Siomou, E. C. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i4.344 · Cited by 129
Evans, M., Engberg, S., Faurby, M. D., Fernandes, J. D. D. R., Hudson, P., & Polonsky, W. H. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14603 · Cited by 119
Alqarni, A. M., Alrahbeni, T. M. A., AlQarni, A. M., & Qarni, H. M. A. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s176355 · Cited by 135
Ravaut, M., Harish, V., Sadeghi, H., Leung, K. K., Volkovs, M., Kornas, K., Watson, T., Poutanen, T., & Rosella, L. C. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.11315 · Cited by 89
Effective interventions to improve medication adherence in Type 2 diabetes: a systematic review
Williams, J. L. S., Walker, R. J., Smalls, B. L., Campbell, J. A., & Egede, L. E. (2014) · Diabetes Management · doi:10.2217/dmt.13.62 · Cited by 84
Self-citationImproving diabetes medication adherence: successful, scalable interventions
Zullig, L. L., Gellad, W. F., Moaddeb, J., Crowley, M. J., Shrank, W. H., Trygstad, T. K., Liu, L., Bosworth, H. B., Granger, B. B., & Granger, C. B. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s69651 · Cited by 96
Trends in Health Care Expenditure in U.S. Adults With Diabetes: 2002–2011
Ozieh, M. N., Bishu, K. G., Dismuke, C. E., & Egede, L. E. (2015) · Diabetes Care · doi:10.2337/dc15-0369 · Cited by 85
Self-citationAdherence and persistence rates of major antidiabetic medications: a review
Lee, D. S. U., & Lee, H. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00785-1 · Cited by 72
“Moreover, low adherence to antidiabetic medications increases healthcare costs and diminishes quality of life [5, 14, 16].”
BackgroundFukuda, H., & Mizobe, M. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.11.007 · Cited by 78
Mayberry, L. S., Egede, L. E., Wagner, J. A., & Osborn, C. Y. (2014) · Journal of Behavioral Medicine · doi:10.1007/s10865-014-9611-4 · Cited by 73
Self-citationPharmacist-provided diabetes management and education via a telemonitoring program
Shane‐McWhorter, L., McAdam‐Marx, C., Lenert, L. A., Petersen, M. J., Woolsey, S., Coursey, J. M., Whittaker, T. C., Hyer, C., LaMarche, D., Carroll, P., et al. (2015) · Journal of the American Pharmacists Association · doi:10.1331/japha.2015.14285 · Cited by 65
Gourzoulidis, G., Kourlaba, G., Stafylas, P., Giamouzis, G., Parissis, J., & Maniadakis, N. (2017) · Health Policy · doi:10.1016/j.healthpol.2017.02.008 · Cited by 62
McSharry, J., McGowan, L. J., Farmer, A. A., & French, D. (2016) · Diabetic Medicine · doi:10.1111/dme.13152 · Cited by 68
Baghikar, S., Benitez, A., Fernandez Piñeros, P., Gao, Y., & Baig, A. A. (2019) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-019-00867-9 · Cited by 61
Fan, Y., Long, E., Cai, L., Cao, Q., Wu, X., & Tong, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.665951 · Cited by 58
“Adherence to the recommended therapy is associated with better glycemic control, fewer complications, risk reduction, and lower medical costs (Egede et al., 2012; McAdam-Marx et al., 2014; Kennedy-Martin et al., 2017; Ting et al., 2021).”
BackgroundRosenstock, J., Buse, J. B., Azeem, R., Prabhakar, P., Kjems, L., Huang, H., & Baron, M. A. (2018) · Diabetes Care · doi:10.2337/dc17-1306 · Cited by 53
Chantzaras, A. E., & Yfantopoulos, J. (2022) · HORMONES · doi:10.1007/s42000-022-00400-y · Cited by 69
The Utah Remote Monitoring Project: Improving Health Care One Patient at a Time
Shane-McWhorter, L., Lenert, L., Petersen, M., Woolsey, S., McAdam-Marx, C., Coursey, J. M., Whittaker, T. C., Hyer, C., LaMarche, D., Carroll, P., et al. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0045 · Cited by 51
“Increased costs may be due to failure to comply with prescribed treatments.(11) One report indicated that increased medication adherence could save $5 billion annually and result in fewer emergency department visits and hospitalizations.”
Application of Extrusion-Based 3D Printed Dosage Forms in the Treatment of Chronic Diseases
Annaji, M., Ramesh, S., Poudel, I., Govindarajulu, M., Arnold, R. D., Dhanasekaran, M., & Babu, R. J. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.09.042 · Cited by 58
Mody, R., Grabner, M., Yu, M., Turner, R., Kwan, A. Y. M., York, W., & Fernández Landó, L. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1421146 · Cited by 50
Long, H. A., Bartlett, Y. K., Farmer, A. A., & French, D. (2018) · Journal of Medical Internet Research · doi:10.2196/10421 · Cited by 53
Persistence and adherence to oral antidiabetics: a population-based cohort study
Simard, P., Presse, N., Roy, L. F., Dorais, M., White‐Guay, B., Räkel, A., & Perreault, S. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0692-x · Cited by 52
Banerji, M. A., & Dunn, J. D. (2013) · PubMed · Cited by 53
Koyanagi, K., Kubota, T., Kobayashi, D., Kihara, T., Yoshida, T., Miisho, T., Miura, T., Sakamoto, Y., Takaki, J., Seo, T., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00212 · Cited by 48
McGovern, A. P., Hinton, W., Calderara, S., Munro, N. M., Whyte, M., & de Lusignan, S. (2018) · Diabetes Therapy · doi:10.1007/s13300-017-0361-5 · Cited by 52
Grandy, S., Hashemi, M., Langkilde, A. ‐., Parikh, S., & Sjöström, C. D. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12263 · Cited by 44
The Special Challenge of Nonadherence With Sublingual Immunotherapy
Bender, B. G., & Oppenheimer, J. J. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.01.003 · Cited by 46
Malmenäs, M., Bouchard, J. R., & Langer, J. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.03.021 · Cited by 43
Balkhi, B. S., Alwhaibi, M., Alqahtani, N., Alhawassi, T. M., Alshammari, T. M., Mahmoud, M. A., AlMetwazi, M. S., Ata, S. I., & Kamal, K. M. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029280 · Cited by 55
Adherencia terapéutica en la enfermedad crónica: estado de la situación y perspectiva de futuro
Conthe, P., Contreras, E. M., Pérez, A. A., García, B., Martín, M. N. F. D. C., Jurado, M. A. G., Baturone, M. O., & Pinto, J. L. (2014) · Revista Clínica Española · doi:10.1016/j.rce.2014.03.008 · Cited by 85
Lynch, C. P., Gebregziabher, M., Axon, R. N., Hunt, K. E., Payne, E., & Egede, L. E. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-2990-y · Cited by 45
Self-citationPreference for a Novel Oral Alternative to Parenterally Administered Medications
Myers, J. T., Dam, J. V., Imran, M., Hashim, M. A., & Dhalla, A. K. (2024) · Patient Preference and Adherence · doi:10.2147/ppa.s463354 · Cited by 38
Mody, R., Yu, M., Nepal, B., Konig, M., & Grabner, M. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14195 · Cited by 35
Cai, J., Divino, V., & Burudpakdee, C. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1320277 · Cited by 35
Cutler, R. L., Torres-Robles, A., Wiecek, E., Drake, B., van der Linden, N., Benrimoj, S. I., & García‐Cárdenas, V. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s191482 · Cited by 56
Out-of-pocket expenditure and drug adherence of patients with diabetes in Odisha
Rout, S. K., Swain, S., Samal, S., & Sahu, K. S. (2018) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_24_18 · Cited by 39
Owolabi, E. O., Goon, D. T., & Ajayi, A. I. (2020) · Medicine · doi:10.1097/md.0000000000018953 · Cited by 35
Reaney, M. D., Elash, C. A., & Litcher‐Kelly, L. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.009 · Cited by 37
“[5] Egede LE, Gebregziabher M, Dismuke CE, Lynch CP, Axon RN, Zhao Y, et al.”
BackgroundTreatment compliance in chronic illness: Current situation and future perspectives
Conthe, P., Contreras, E. M., Pérez, A. A., García, B., Martín, M. N. F. D. C., Jurado, M. A. G., Baturone, M. O., & Pinto, J. L. (2014) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2014.03.003 · Cited by 38
Patel, P., Gupta, P., Burns, A., Suwaidan, A. A., Cole, R., Lane, D., Seidu, S., & Khunti, K. (2019) · Diabetes Care · doi:10.2337/dc18-1453 · Cited by 32
Perez‐Nieves, M., Boye, K. S., Kiljanski, J. I., Cao, D., & Lage, M. J. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0421-5 · Cited by 32
Masaba, B. B., & Mmusi-Phetoe, R. (2021) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s270137 · Cited by 39
“Diabetes medication adherence and hemoglobin A1c appear to be inversely related.(14) Achieving glycemic control and preventing early complications are the ultimate targets of diabetes management which depends on patient’s adherence to regimens.”
BackgroundMikhael, E. M., Hussain, S. A., Shawky, N., & Hassali, M. A. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000658 · Cited by 32
Hussain, N., Said, A. S. A., & Khan, Z. (2019) · International Quarterly of Community Health Education · doi:10.1177/0272684x19896724 · Cited by 35
Epstein, L. H., Jimenez-Knight, T., Gentile, A. M., Paluch, R. A., & Bickel, W. K. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s342118 · Cited by 30
Pagano, E., Petrelli, A., Picariello, R., Merletti, F., Gnavi, R., & Bruno, G. (2015) · BMC Health Services Research · doi:10.1186/s12913-015-1241-1 · Cited by 23
Barba, E. L., de Miguel, M. R., Hernández‐Mijares, A., Alonso-Moreno, F. J., Peña, M. L. O., Aceituno, S., & Dáder, M. J. F. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s122556 · Cited by 31
Long-term Effects of Disasters on Seniors With Diabetes: Evidence From Hurricanes Katrina and Rita
Quast, T. C., Andel, R., & Sadhu, A. (2019) · Diabetes Care · doi:10.2337/dc19-0567 · Cited by 30
Khairnar, R. R., Kamal, K. M., Giannetti, V. J., Dwibedi, N., & McConaha, J. L. (2018) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2018.05.003 · Cited by 27
Prevalence and predictors of primary nonadherence to medications prescribed in primary care
Zeitouny, S., Cheng, L., Wong, S. T., Tadrous, M., McGrail, K. M., & Law, M. R. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.221018 · Cited by 31
Cheng, J. S., Tsai, W., Lin, C.-L., Chen, L., Lang, H., Hsieh, H., Shin, S.-J., Chen, T., Huang, C.-T., & Hsu, C.-C. (2014) · Medical Care · doi:10.1097/mlr.0000000000000288 · Cited by 25
Integration of Medication Management Into Occupational Therapy Practice
Schwartz, J. K., & Smith, R. O. (2017) · American Journal of Occupational Therapy · doi:10.5014/ajot.2017.015032 · Cited by 29
“Because of the increased time in the hospital, people who are nonadherent to their medications spend an average of 41% more than their adherent peers on inpatient health care (Egede et al., 2012; Sokol et al., 2005).”
BackgroundLane, D., Patel, P., Khunti, K., & Gupta, P. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s162215 · Cited by 29
Medication non-adherence in patients with type 2 diabetes mellitus with full access to medicines
Saraiva, E. M. S., Coelho, J. L. G., Figueiredo, F. W. D. S., & do Souto, R. P. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00612-2 · Cited by 25
“In addition, non-adherence to antidiabetic pharmacotherapy is associated with increased costs to the health system [9].”
BackgroundImproving medication adherence: a framework for community pharmacy-based interventions
Pringle, J. L., & Coley, K. C. (2015) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s93036 · Cited by 30
Andreae, S. J., Andreae, L. J., Cherrington, A., Richman, J., Johnson, E., Clark, D., & Safford, M. M. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106358 · Cited by 23
Diabetes Mellitus—Digital Solutions to Improve Medication Adherence: Scoping Review
Georgieva, N., Tenev, V., Kamusheva, M., & Petrova, G. I. (2023) · Diabetology · doi:10.3390/diabetology4040040 · Cited by 27
Sönmez, A., Taşçı, İ., Demirci, İ., Haymana, C., Barçın, C., Aydin, H., Çetinkalp, Ş., Öztürk, F. Y., Gül, K., Sabuncu, T., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00779-0 · Cited by 18
Ayyala-Somayajula, D., Dodge, J. L., Farias, A. J., Terrault, N. A., & Lee, B. P. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.020 · Cited by 23
Svensson, A., Toll, A., Lebrec, J., Miftaraj, M., Franzén, S., & Eliasson, B. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14276 · Cited by 17
Type 2 diabetes in children and adolescents: Challenges for treatment and potential solutions
Jia, I. L. J., Zampetti, S., Pozzilli, P., & Buzzetti, R. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111879 · Cited by 31
Egede, L. E., Gebregziabher, M., Zhao, Y., Dismuke, C. E., Walker, R. J., Hunt, K. J., & Axon, R. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103804 · Cited by 17
Self-citationCan Health Care Organizations Improve Health Behavior and Treatment Adherence?
Bender, B. G. (2013) · Population Health Management · doi:10.1089/pop.2013.0045 · Cited by 25
Teló, G. H., de Souza, M. S., & Schaan, B. D. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-141 · Cited by 19
Novel Type 2 Diabetes Medication Access and Effect of Patient Cost Sharing
Henk, H. J., Lopez, J. M. S., & Bookhart, B. (2018) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2018.24.9.847 · Cited by 19
Pednekar, P. P., Heller, D. A., & Peterson, A. M. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.9.1099 · Cited by 28
HIGHTON, P. J., Funnell, M. P., Gupta, P., Zaccardi, F., Lim, L., Seidu, S., & Khunti, K. (2025) · Diabetologia · doi:10.1007/s00125-025-06617-x · Cited by 36
Eby, E. L., Bajpai, S., Faries, D. E., Haynes, V. S., & Lage, M. J. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.9.1081 · Cited by 19
Medication adherence issues in patients: focus on cost
Matsui, D. M. (2013) · Clinical Audit · doi:10.2147/ca.s30125 · Cited by 19
Kharjul, M. D., Braund, R., & Green, J. (2018) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-018-0606-z · Cited by 17
Ofori‐Asenso, R., Liew, D., Lalic, S., Mazidi, M., Magliano, D. J., Ademi, Z., Bell, J. S., & Ilomäki, J. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01077-3 · Cited by 19
Comparative adherence to oral hormonal agents in older women with breast cancer
Cheung, W. Y., Lai, E. C., Ruan, J. Y., Chang, J. T., & Setoguchi, S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3455-7 · Cited by 15
Kong, X., Luo, M.-H., Cai, L., Zhang, P., Yan, R., Hu, Y., Li, H., & Ma, J. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1863945 · Cited by 15
3D printed medicine for the management of chronic diseases: The road less travelled
Varghese, R., Salvi, S., Sood, P., Karsiya, J., & Kumar, D. (2021) · Annals of 3D Printed Medicine · doi:10.1016/j.stlm.2021.100043 · Cited by 14
Brandl, B., Eder, S., Palanisamy, A., Heupl, S., Terzić, I., Katschnig, M., Nguyen, T., Senck, S., Roblegg, E., & Spoerk, M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124356 · Cited by 13
Current Perspectives for Treating Adolescents with Obesity and Type 2 Diabetes: A Review
Niechciał, E., Wais, P., Bajtek, J., & Kędzia, A. W. (2024) · Nutrients · doi:10.3390/nu16234084 · Cited by 26
Zhu, V. J., Tu, W., Rosenman, M. B., & Overhage, J. M. (2014) · PubMed Central · Cited by 13
Wang, X., Li, X., Qie, S., Zheng, Y., Liu, Y., & Liu, G. (2018) · Medicine · doi:10.1097/md.0000000000011946 · Cited by 16
Chang, H., Kan, H. J., Shermock, K. M., Alexander, G. C., Weiner, J. P., & Kharrazi, H. H. K. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.10.1282 · Cited by 14
Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR
Vivian, E., & Kuecker, C. (2016) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s81565 · Cited by 26
Taber, D. J., Ward, R. C., Axon, R. N., Walker, R. J., Egede, L. E., & Gebregziabher, M. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019828681 · Cited by 14
Self-citationWeeda, E. R., Bishu, K. G., Ward, R. C., Axon, R. N., Taber, D. J., & Gebregziabher, M. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01730-8 · Cited by 13
Self-citationSoyoon, K., & Malova, E. (2022) · American Journal of Health Promotion · doi:10.1177/08901171211068401 · Cited by 17
Farahani, I., Farahani, S., Deters, M. A., Schwender, H. R., & Laeer, S. (2020) · Pharmacy · doi:10.3390/pharmacy8040229 · Cited by 14
Metadata
- Authors
- Egede, L. E., Gebregziabher, M., Dismuke, C. E., Lynch, C. P., Axon, R. N., Zhao, Y., & Mauldin, P. D.
- Affiliations
- Medical University of South Carolina (US)
- Corresponding author
- Egede, Leonard E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-11-14
- Volume
- 35
- Issue
- 12
- Pages
- 2533-2539
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3507586
- OpenAlex
- W2147325147
- Cited by
- 195
- References
- 33
- Citations by year
- 2026: 2 · 2025: 14 · 2024: 13 · 2023: 7 · 2022: 9 · 2021: 17 · 2020: 23 · 2019: 15 · 2018: 20 · 2017: 12 · 2016: 17 · 2015: 16 · 2014: 20 · 2013: 9 · 2012: 1
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Health Services Research and Development
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- medication non-adherence, type 2 diabetes, health care costs, medication possession ratio, cost reduction, veterans, hospital costs, outpatient costs, pharmacy costs, generalized linear mixed models, Triple Aim
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Models, Statistical, Drug Monitoring, Cost Savings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.